Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Allergy, Asthma & Clinical Immunology
Published in: Allergy, Asthma & Clinical Immunology 1/2016

Open Access 01-12-2016 | Review

Potential factors involved in the causation of rhabdomyolysis following status asthmaticus

Authors: Hongmei Qiao, Huanji Cheng, Li Liu, Jianing Yin

Published in: Allergy, Asthma & Clinical Immunology | Issue 1/2016

Login to get access

Abstract

Rhabdomyolysis is a rare but potentially fatal complication of status asthmaticus. Since the first case was reported in 1978, only a few dozen cases have been described till date. We performed a literature review with the aim to characterize the pathophysiological basis of the occurrence of rhabdomyolysis in patients with status asthmaticus. Excessive exertion of respiratory muscles, hypoxia and acidosis, electrolyte imbalance, infections, some drugs used for asthma control, use of mechanical ventilation, prolonged cardiopulmonary resuscitation, higher age of the patient and some underlying diseases or genetic factors appear to be involved in its causation. In patients with status asthmaticus, it is important to pay more attention to these factors and to closely monitor creatine kinase levels in blood so as to ensure early detection of rhabdomyolysis.
Literature
1.
2.
Chugh KS, Singhal PC, Khatri GK. Rhabdomyolysis and renal failure following status asthmaticus. Chest. 1978;73:879–80.CrossRefPubMed
3.
Goh AY, Chan PW. Acute myopathy after status asthmaticus: steroids, myorelaxants or carbon dioxide? Respirology. 1999;4:97–9.CrossRefPubMed
4.
Li AM, Li CC, Chik KW, Shing MM, Fok TF. Rhabdomyolysis following status asthmaticus. J Paediatr Child Health. 2001;37:409–10.CrossRefPubMed
5.
Carroll CL, Zucker AR. The increased cost of complications in children with status asthmaticus. Pediatr Pulmonol. 2007;42:914–9.CrossRefPubMed
6.
Mehta R, Fisher LE Jr, Segeleon JE, Pearson-Shaver AL, Wheeler DS. Acute rhabdomyolysis complicating status asthmaticus in children: case series and review. Pediatr Emerg Care. 2006;22:587–91.CrossRefPubMed
7.
Barrett SA, Mourani S, Villareal CA, Gonzales JM, Zimmerman JL. Rhabdomyolysis associated with status asthmaticus. Crit Care Med. 1993;21:151–3.CrossRefPubMed
8.
Lu QH, Cheng HJ, Liu L, Qiao HM, Yu XH. Rhabdomyolysis following status asthmaticus: a case report. Chin Pediatr Emerg Med. 2013;20:110–1 (in Chinese).
9.
Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006;118:2119–25.CrossRefPubMed
10.
Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis—an overview for clinicians. Crit Care. 2005;9:158–69.CrossRefPubMed
11.
Makaryus JN, Catanzaro JN, Katona KC. Exertional rhabdomyolysis and renal failure in patients with sickle cell trait: is it time to change our approach? Hematology. 2007;12:349–52.CrossRefPubMed
12.
Criddle LM. Rhabdomyolysis pathophysiology, recognition, and management. Crit Care Nurse. 2003;23:14–32.PubMed
13.
Bando T, Fujimura M, Noda Y, Ohta G, Matsuda T. Rhabdomyolysis following status asthmaticus. Respiration. 1996;63:309–11.CrossRefPubMed
14.
Chen YJ, Chang SH, Yuan A, Huang CH, Lee CC. Rhabdomyolysis after successful resuscitation of a patient with near-fatal asthma. Am J Emerg Med. 2007;25:736 (e3–4).PubMed
15.
Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med. 1974;291:807–11.CrossRefPubMed
16.
Trimarchi H, Gonzalez J, Olivero J. Hyponatremia-associated rhabdomyolysis. Nephron. 1999;82:274–7.CrossRefPubMed
17.
Cheney P. Early management and physiologic changes in crush syndrome. Crit Care Nurs Q. 1994;17:62–73.CrossRefPubMed
18.
19.
Campistol JM, Perez Villa F, Montoliu J, Moreno A, Revert L. Rhabdomyolysis and acute renal failure associated with Salmonella enteritidis infection. J Hosp Infect. 1989;14:267–8.CrossRefPubMed
20.
Guis S, Mattei JP, Cozzone PJ, Bendahan D. Pathophysiology and clinical presentations of rhabdomyolysis. Joint Bone Spine. 2005;72:382–91.CrossRefPubMed
21.
Naschitz JE, Yeshurun D, Shagrawi I. Rhabdomyolysis in pneumococcal sepsis. Am J Med. 1989;87:479–80.CrossRefPubMed
22.
Brncic N, Viskovic I, Sasso A, Kraus I, Zamolo G. Salmonella infection-associated acute rhabdomyolysis. Some pathogenic considerations. Arch Med Res. 2002;33:313–5.CrossRefPubMed
23.
Bagnulo H, Rodríguez F. Rhabdomyolysis during a case of streptococcal toxic shock syndrome. Enferm Infecc Microbiol Clin. 2001;19:82–3 (in Spanish).CrossRefPubMed
24.
Malvy D, Dessalles PH, Monseau Y, Bonhoure JB. Legionnaire’s disease and rhabdomyolysis. Intensiv Care Med. 1992;18:132–3.CrossRef
25.
Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis. 1996;22:642–9.CrossRefPubMed
26.
Ayala E, Kagawa FT, Wehner JH, Tam J, Upadhyay D. Rhabdomyolysis associated with 2009 influenza A (H1N1). JAMA. 2009;302:1863–4.CrossRefPubMed
27.
Oishi T, Narita M, Ohya H, Yamanaka T, Aizawa Y, Matsuo M, et al. Rhabdomyolysis associated with antimicrobial drug-resistant Mycoplasma pneumoniae. Emerg Infect Dis. 2012;18:849–51.CrossRefPubMedPubMedCentral
28.
Williams TJ, O’Hehir RE, Czarny D, Hörne M, Bowes G. Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. Am Rev Respir Dis. 1988;137:460–3.CrossRefPubMed
29.
Dirks-Naylor AJ, Griffiths CL. Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy. J Steroid Biochem Mol Biol. 2009;117:1–7.CrossRefPubMed
30.
Gayan-Ramirez G, Decramer M. The effect of corticotherapy on respiratory muscles. Rev Mal Respir. 1998;15:33–41 (in French).PubMed
31.
Behbehani NA, Al-Mane F, D’yachkova Y, Paré P, FitzGerald JM. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest. 1999;115:1627–31.CrossRefPubMed
32.
Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med. 1996;153:1686–90.CrossRefPubMed
33.
Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest. 1992;102:510–4.CrossRefPubMed
34.
Road J, Mackie G, Jiang TX, Stewart H, Eisen A. Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiological correlates. Muscle Nerve. 1997;20:1587–90.CrossRefPubMed
35.
DuBois DC, Almon RR. A possible role for glucocorticoids in denervation atrophy. Muscle Nerve. 1981;4:370–3.CrossRefPubMed
36.
Larsson L, Li X, Edström L, Eriksson LI, Zackrisson H, Argentini C, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med. 2000;28:34–45.CrossRefPubMed
37.
Craig TJ, Smits W, Soontornniyomkiu V. Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol. Ann Allergy Asthma Immunol. 1996;77:488–90.CrossRefPubMed
38.
Craig VL, Bigos D, Brilli RJ. Efficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus. Pediatr Emerg Care. 1996;12:1–5.PubMed
39.
Blake PG, Ryan F. Rhabdomyolysis and acute renal failure after terbutaline overdose. Nephron. 1989;53:76–7.CrossRefPubMed
40.
Bradberry SM, Vale JA. Disturbances of potassium homeostasis in poisoning. J Toxicol Clin Toxicol. 1995;33:295–310.CrossRefPubMed
41.
Macdonald JB, Jones HM, Cowan RA. Rhabdomyolysis and acute renal failure after theophylline overdose. Lancet. 1985;1:932–3.CrossRefPubMed
42.
Rumpf KW, Wagner H, Criee CP, Schwarck H, Klein H, Kreuzer H, et al. Rhabdomyolysis after theophylline overdose. Lancet. 1985;1:1451–2.CrossRefPubMed
43.
44.
Aoshima M, Kameyama S, Murai Y, Yamazaki M, Kamiya T, Miyazaki T. A case of theophylline-induced rhabdomyolysis following therapy of bronchial asthma. Nihon Kyobu Shikkan Gakkai Zasshi. 1991;29:1064–9 (in Japanese).PubMed
45.
Laurence AS, Wight J, Forrest AR. Fatal theophylline poisoning with rhabdomyolysis. Anaesthesia. 1992;47:82.CrossRefPubMed
46.
Tsai J, Chern TL, Hu SC, Lee CH, Wang RB, Deng JF. The clinical implication of theophylline intoxication in the Emergency Department. Hum Exp Toxicol. 1994;13:651–7.CrossRefPubMed
47.
Titley OG, Williams N. Theophylline toxicity causing rhabdomyolysis and acute compartment syndrome. Intensiv Care Med. 1992;18:129–30.CrossRef
48.
Iwano J, Nakamura Y, Izumida T, Yokota M, Takiguchi Y, Minakuchi K, et al. Synergistic effect of combining theophylline and drugs that potentially elevate serum creatine kinase. J Med Invest. 2000;47:9–13.PubMed
49.
50.
51.
52.
Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensiv Care Med. 2003;29:1417–25.CrossRef
53.
Mehta N, DeMunter C, Habibi P, Nadel S, Britto J. Short-term propofol infusions in children. Lancet. 1999;354:866–7.CrossRefPubMed
54.
Schenkman KA, Yan S. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med. 2000;28:172–7.CrossRefPubMed
55.
Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000;46:577–81.PubMed
56.
Fudickar A, Bein B. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol. 2009;75:339–44.PubMed
57.
Short TG, Young Y. Toxicity of intravenous anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17:77–89.CrossRefPubMed
58.
Coetzee JF, Coetzer M. Propofol in paediatric anaesthesia. Curr Opin Anaesthesiol. 2003;16:285–90.CrossRefPubMed
59.
Guis S, Jouglard J, Kozak-Ribbens G, Figarella-Branger D, Vanuxem D, Pellissier JF, et al. Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment. J Rheumatol. 2001;28:1405–6.PubMed
60.
Gupta A, Guron N, Harris M, Bell R. Levofloxacin-induced rhabdomyolysis in a hemodialysis patient. Hemodial Int. 2012;16:101–3.PubMed
61.
Brener ZZ, Bilik I, Khorets B, Winchester JF, Bergman M. Rhabdomyolysis following clarithromycin monotherapy. Am J Med Sci. 2009;338:78.CrossRefPubMed
62.
Carroll MW, Choi H, Min S, Hwang S, Park H, Song T, et al. Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis. Clin Infect Dis. 2012;54:1624–7.CrossRefPubMedPubMedCentral
63.
Lucas da Silva PS, Iglesias SB, Waisberg J. Hypokalemic rhabdomyolysis in a child due to amphotericin B therapy. Eur J Pediatr. 2007;166:169–71.CrossRefPubMed
64.
Shimada N, Omuro H, Saka S, Ebihara I, Koide H. A case of acute renal failure with rhabdomyolysis caused by the interaction of theophylline and clarithromycin. Nihon Jinzo Gakkai Shi. 1999;41:460–3 (in Japanese).PubMed
65.
Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet. 2000;38:41–57.CrossRefPubMed
66.
Ferrari M, Bodini I, Lo Cascio V. Rhabdomyolysis after the administration of itraconazole to an asthmatic patient with bronchopulmonary aspergillosis. Respiration. 2004;71:289–91.CrossRefPubMed
67.
Eisenburger P, Laggner AN, Lenz K, Druml W. Acute renal failure and rhabdomyolysis after inadvertent intra-arterial infusion of excessive doses of epinephrine during cardiopulmonary resuscitation. Wien Klin Wochenschr. 2000;112:174–6.PubMed
68.
Hojs R, Sinkovic A, Hojs-Fabjan T. Rhabdomyolysis and acute renal failure following cardioversion and cardiopulmonary resuscitation. Ren Fail. 1995;17:765–8.CrossRefPubMed
69.
Biswas S, Gnanasekaran I, Ivatury RR, Simon R, Patel AN. Exaggerated lithotomy position-related rhabdomyolysis. Am Surg. 1997;63:361–4.PubMed
70.
DuBois DC, Almon RR. Disuse atrophy of skeletal muscle is associated with an increase in number of glucocorticoid receptors. Endocrinology. 1980;107:1649–51.CrossRefPubMed
71.
Tsushima K, Koyama S, Ueno M, Fujimoto K, Ichiyoshi T, Takei Y, et al. Rhabdomyolysis triggered by an asthmatic attack in a patient with McArdle disease. Intern Med. 2001;40:131–4.CrossRefPubMed
72.
Gilad J, Pirogovsky A, Bartal C. Unmasking of carnitine palmitoyltransferase deficiency during an acute exacerbation of asthma complicated by rhabdomyolysis in a soldier. Mil Med. 2004;169:821–3.CrossRefPubMed
73.
Alshanti M, Eledrisi MS, Jones E. Rhabdomyolysis associated with hyperthyroidism. Am J Emerg Med. 2001;19:317.CrossRefPubMed
74.
Casteels K, Beckers D, Wouters C, Van Geet C. Rhabdomyolysis in diabetic ketoacidosis. Pediatr Diabetes. 2003;4:29–31.CrossRefPubMed
75.
76.
Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014;24:651–9.CrossRefPubMed
77.
Feng Q. Approach to clinical and genetic characterization of statin-induced myopathy. Methods Mol Biol. 2014;1175:67–90.CrossRefPubMed
78.
Yamin C, Meckel Y, Oliveira J, Duarte JA, Ben-Zaken S, Nemet D, et al. Genetic aspects of exercise and rhabdomyolysis. Pediatr Endocrinol Rev. 2014;11:400–8.PubMed
79.
Deuster PA, Contreras-Sesvold CL, O’Connor FG, Campbell WW, Kenney K, Capacchione JF, et al. Genetic polymorphisms associated with exertional rhabdomyolysis. Eur J Appl Physiol. 2013;113:1997–2004.CrossRefPubMed
Metadata
Title
Potential factors involved in the causation of rhabdomyolysis following status asthmaticus
Authors
Hongmei Qiao
Huanji Cheng
Li Liu
Jianing Yin
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Allergy, Asthma & Clinical Immunology / Issue 1/2016
Electronic ISSN: 1710-1492
DOI
https://doi.org/10.1186/s13223-016-0149-6

Other articles of this Issue 1/2016

Allergy, Asthma & Clinical Immunology 1/2016 Go to the issue

Research

Filaggrin gene mutations and new SNPs in asthmatic patients: a cross-sectional study in a Spanish population

Research

Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children

Research

Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU)

Research

Clinical and immuno-proteomic approach on Lantana camara pollen allergy—a major health hazard

Research

Association between cancer and allergies

Research

Gene mutations responsible for primary immunodeficiency disorders: A report from the first primary immunodeficiency biobank in Iran